Molecular details provide new answer for heart-threatening chemotherapy
An effective drug that kills cancer by damaging DNA also attacks heart muscle, which for some patients leads to heart failure. In new research, scientists have discovered how the drug attacks the heart, opening potential new options to prevent or minimize the life-threatening side effect.
Doxorubicin is a 50-year-old chemotherapy drug still in widespread use in combinations to treat...
Depression, telomere length double-team bladder cancer patients
According to data from the National Cancer Institute's SEER database, less than 50% of patients with stage three bladder cancer will survive...
Routine blood test predicts risk of developing liver cancer
A simple measure of liver function routinely taken via blood tests at physical exams and other doctor's visits turns out to be highly predictive...
AACR: An annual meeting of "like minds" in cancer prevention
One of the most collaborative meetings of researchers in basic, clinical, behavioral and epidemiological science focused on cancer prevention, the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research, is taking place in Anaheim, CA, this week.
A plethora of professionals is expected to attend this year's conference, which focuses on scientific and lifestyle strategies to prevent cancer. With hundreds...
Institute of Medicine elects Lynda Chin to membership
Lynda Chin, M.D., professor and chair of MD Anderson's Department of Genomic Medicine and scientific director of the Institute for Applied...